Aisling Capital IV, LP

Insider Buys Quantity –
2
2021-06-29PurchaseElevation Oncology, Inc.
ELEV
10 percent owner
187,500
22.5074%
$16.00$3M-56%
2019-07-15PurchaseViracta Therapeutics, Inc.
VIRX
10 percent owner
2.5M
1.66%
$0.60$1.5M-41.86%